Advancements in Sepsis
|
|
- Tracy Gibbs
- 5 years ago
- Views:
Transcription
1 Objectives Advancements in Sepsis Brian Gilbert, PharmD PGY-1 Pharmacy Resident Jackson Memorial Hospital 3/13/ Pharmacist objectives Review recent updates in resuscitation strategies Describe different monitoring updates Analyze appropriate use of adjuvant therapies Pharmacy Technician objectives Describe pathophysiology of sepsis Define systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock List guideline recommended sepsis treatment goals 3 Disclosure I have no disclosures to report. Epidemiology Sepsis is a leading cause of death in the U.S. and most common among ICU patients The associated cost of treating septic patients is rising with an estimated cost of $24 billion in 2013 Sepsis mortality rates have been reported as high as 60% End organ damage is the strongest predictor of mortality 2 Virulence Jan 1; 5(1):
2 Risk Factors for Development of Sepsis Host Response to Sepsis Age Elderly Neonatal Immunocompromised Solid organ transplant HIV Diabetes Predisposing comorbidities COPD Cancers Recent hospitalization Prior antimicrobial exposure within past 30 days Prior hospitalization within past 90 days Ann Epidemiol Jan;26(1): N Engl J Med 2013; 369: Inflammatory Mediators Pathophysiology of Organ Failure Pro-inflammatory Interleukin-1,6,12 TNFa Anti-inflammatory Interleukin-4,10 TGF-β 6 N Engl J Med 2013; 369:
3 Sepsis As A Continuum? Systemic Inflammatory Response Syndrome (SIRS) Criteria Variable Fever Description >38 C or<36 C White blood cell count >12,000 or <4,000 Heart rate Tachypnea > 90 beats per minute > 20 breaths/min SIRS Sepsis Severe Sepsis Septic Shock Thrombocytopenia <100,000 Hyperlactatemia Creatinine >1 mmo/l Increase >0.5 mg/dl 9 11 Hot Off The Presses! Sepsis SIRS criteria + JAMA. 2016;315(8): JAMA. 2016;315(8):
4 New Sepsis Definition Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection Variable Urine output Acute lung injury Acute lunginjury Creatinine Bilirubin Severe Sepsis Description <0.5 ml/kg/hr for more than 2 hours despite adequate fluid PaO2/FiO2 <250 in the absence of pneumonia PaO2/FiO2 <200 in the presence of pneumonia > 2.0 mg/dl > 2 mg/dl Platelet count < 100,000 INR > 1.5 JAMA. 2016;315(8): Sequential Organ Failure Assessment New Severe Sepsis The task force emphasis on life-threatening organ dysfunction is consistent with the view that cellular defects underlie physiologic and biochemical abnormalities within specific organ systems. Under this terminology, severe sepsis "becomes superfluous. JAMA. 2016;315(8): JAMA. 2016;315(8):
5 Septic Shock Definitions Summary Sepsis + hypotension refractory to fluid resuscitation Complex disease state with poorest prognosis Old Classification SIRS nonspecific signs of inflammation Sepsis SIRS + suspected infection New Classification SOFA quantitative measure of organ failure Sepsis organ dysfunction caused by dysregulated host response to infection; SOFA >2 Severe sepsis sepsis induced organ failure Severesepsis all sepsis is associated with organ failure; therefore severe sepsis is redundant Septic shock sepsis inducedhypotension refractory to fluids Septic shock subsetof sepsis defined by persistent hypotension requiring vasopressors to maintain MAP = 65 mmhg despite adequate fluid resuscitation 19 New Septic Shock Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality.persisting hypotension requiring vasopressors to maintain MAP=65 mmhg and having a serum lactate level > 3 mg/dl despite adequate volume resuscitation Current Recommended Surviving Sepsis Campaign Treatment Goals To be completed in 3 hours: Measure lactate level Obtain blood cultures prior to antibiotic administration Broad spectrum antibiotics Administer 30 ml/kg of crystalloids for hypotension or lactate > 4mmol/L To be completed in 6 hours: Apply vasopressors for fluid refractory hypotension Measure central venous pressure (CVP), central venous oxygen saturation (ScVO2) Re-measure lactate levels JAMA. 2016;315(8):
6 Rivers et. al (2001) Foundation of early goal directed therapy (EGDT) EGDT group: received more fluids, vasopressors, and RBCs Mortality 28 day and 60 day mortality 30.5% vs. 46.5% in hospital mortality (p=0.009) The Rivers Trial The PROCESS Trial Randomized un-blinded controlled trial Objective: To determine effectiveness of EGDT Primary endpoint:60 day mortality N=1341 septic shock patients from 31 U.S. academic centers Three study groups: EGDT; protocolizedstandard therapy (PST); usual care N Engl J Med. 2001;345(19): N Engl J Med 2014;370: Recent Challenges to the Rivers Trial The PROCESS Trial The PROCESS Trial Results Group (n) 60 day mortality (%) Average ICU days 90 day mortality (%) The ARISE Trial EGDT (439) PST (446) Usual Care (456) 92 (21.0) 81 (18.2) p= (18.9) 5.1± ±7.1 p= ± (31.9) 128 (30.8) p= (33.7) The PROMISE Trial N Engl J Med 2014;370: N Engl J Med 2014; 371: N Engl J Med 2015; 372: N Engl J Med 2014;370:
7 The ARISE Trial The PROMISE Trial Randomized un-blinded controlled trial Randomized un-blinded controlled trial Objective: To determine effectiveness of EGDT Objective: To determine the effectiveness of EGDT Primary endpoint: 90 day mortality Primary endpoint: 90 day all cause mortality N=1591 septic shock patients from New Zealand and Australia N=1251 septic shock patients from the U.K. Two study groups: EGDT; usual care Two study groups: EGDT; usual care N Engl J Med 2014; 371: N Engl J Med 2015; 372: The ARISE Trial Results The PROMISE Trial Results N Engl J Med 2014; 371: N Engl J Med 2015; 372:
8 EGDT Final Challenge Albumin Use in Septic Shock Meta-analysis; n=4735 Angus et al Rivers Trial (2001) Jones Trial (2010) PROCESS (2014) ARISE (2014) PROMISE (2015) Intensive Care Med. (2015) 41: Results Mortality No difference between control group vs. EGDT p=0.90 Organ support Vasopressor use increased in EGDT group p<0.001 ICU length of stay EGDT was associated with higher ICU admission p< Increases oncotic pressure and increased intravascular volume Antioxidant and anti-inflammatory properties Acts as a buffer for acid-base equilibrium SSC recommends the use of albumin for severe sepsis and septic shock patients who require large volumes of crystalloids (grade 2C) N Engl J Med. 2014; 370(18): Surviving Sepsis Campaign (SSC) Update ALBIOS Trial n=1795 Randomized controlled trial Objective: To establish effectiveness of daily albumin replacement in patients with severe sepsis Randomized to receive either crystalloids ±20% albumin daily Primary outcome: 28 day mortality 30 N Engl J Med. 2014; 370(18):
9 ALBIOS Results SEPSISPAM Trial Albumin Replacement Group No difference in 28 day mortality between both groups (p=0.94) Higher liver and coagulation SOFA sub-scores Shorter amount of time spent on vasopressors (p=0.007) Crystalloids Only Group No difference in time spent on mechanical ventilation, RRT, or reported acute kidney injuries No difference in ICU or hospital length of stay Lower cardiovascular SOFA subscore Multi-center open label randomized trial Objective: To determine if higher MAPs during septic shock would lead to lower mortality N=776 septic shock patients Patients were stratified into two groups; MAP (80-85) or MAP (65-70) N Engl J Med. 2014; 370(18): N Engl J Med Apr 24; 370(17): Mean Arterial Pressure (MAP) in Sepsis Observational studies have shown association between MAP > 65 and good clinical outcomes Indirect sign of systemic perfusion Individualize to patients SEPSISPAM Results Outcome Lower Target; n (%) Higher Target; n (%) p Value 28 day mortality 132 (34.0) 142(36.6) day mortality 164 (42.3) 170 (43.8) 0.74 Avg. days of vasopressor therapy 3.7 ± ± Organ support at day (62.1) 235 (60.6) 0.66 Rate of new onset A-fib 11 (2.8) 26(6.7) 0.02 Initial 6 hour SSC bundle calls for maintaining MAP > 65 Fluids Vasopressors 34 N Engl J Med Apr 24; 370(17):
10 TRISS Trial Biomarkers SSC Recommendations are to transfuse patients in septic shock to maintain hematocrit > 30% in first 6 hours of resuscitation Hemoglobin should be maintained 7-9 g/dl in most patients Data is limited to support these recommendations n=998 patients Multicenter randomized parallel-group trial Stratified to receive transfusion based off their hemoglobin (<7 or <9) All transfusions consisted of one unit of packed red blood cells N Engl J Med (15): TRISS Results ProcalcitoninRole in Sepsis Production is increased during bacterial infections Mixed data on its utility in critically ill patients SSC suggests that low procalcitonin(pct) can assist for the discontinuation of antibiotics (Low level of evidence; 2C) No consensus on cut off values or initial PCT value as it relates to sight and severity of sepsis Highly specific Low sensitivity N Engl J Med (15): Am J Respir Crit Care Med Nov 15;190(10) 40 10
11 Procalcitonin Selenium Shehabi et al. (2014); n=394 Blinded RCT PCT algorithm in critically ill adults with suspected sepsis or undifferentiated infection Primary outcome: Time to antibiotic cessation, hospital discharge or death Am J Respir Crit Care Med Nov 15;190(10) PCT Algorithm 1) Cease antibiotics if: Initial or any subsequent PCT value is <0.10 ng/ml Initial or any subsequent PCT value is ng/ml where infection is highly unlikely Subsequent PCT levels have decreased 90% of baseline 2) Asses antibiotic appropriateness and/or adequacy of source control if PCT level at 48 hours > 70% of baseline 41 Oxidative stress in the form of reactive oxygen species is associated with multi-organ failure Selenium is an important precursor in the development of free radical scavengers It causes positive immune modulation in vivo Serum selenium values are lower amongst septic patients SSC does not recommend the use of IV selenium (grade 2C) J Crit Care Feb;29(1): Study Results Selenium Supplementation Study Group Intervention Mortality Benefit LOS Benefit MV Benefit Mishraet al (2007) Angstwurm etal (2007) Valenta et al (2011) Angstwurm et al (1999) Continuousinfusion of 474 μg x 3 days 1 mg bolus;then 1 mg continuous infusion x 14 days 1 mg bolus;then 1.5 mg continuous infusion x 14 days 535μg x 3 days 285 μg x 3 days 155 μg x 3 days No N/A N/A N/A Yes Yes N/A N/A Yes No No No Am J Respir Crit Care Med Nov 15;190(10) 42 Crit Care, 11 (2007), p. R73 Crit Care Med, 26 (1998), pp Intensive Care Med, 27 (2001), pp Intensive Care Med, 37 (2011), pp J Crit Care Feb;29(1):
12 Ascorbic Acid (AA) Methylene Blue Proposed antioxidant and antiinflammatory effects on the microvasculature Enhanced cell signaling in vasculature cells Role in endogenous catecholamine synthesis SSC has no statement on the use of AA Improves vascular tone and perfusion to tissues Inhibits nitric oxide induced guanylate cyclase activation preventing smooth muscle relaxation Limited data on dose and duration SSC has no statement on the use of methylene blue in septic patients Critical Care 2015, 19: Pharmacotherapy 2010;30(7): Ascorbic Acid in the Literature Methylene Blue (MB) in the Literature Study; n Design Intervention Outcomes Nathenset al; 301 RCT AA 1 g PO TID Pulmonary morbidity, new MOF, LOS ven la on, LOS ICU Crimi et al; 105 RCT AA 500 mgq24h Ventilator-free days, 28-day mortality Collier at al; 2,727 QE* IV or PO AA 1 g TID Berger et al;102 RCT AA 2.7g IV x 1 days AA 1.6 g IV x 4 days Heylandet al;307 RCT AA1.5 g IV or PO q24h LOS ICU, LOS hospital, mortality ; OR 0.32, 95 % CI 0.22 to 0.46 New organ failure ND, new infections ND, LOS shorter in trauma, CRP in cardiac surgery and trauma, recovery of health a er discharge ND in 28-day mortality or length of stay Design Population MB Regimens Prospective randomized open-label, placebo controlled, single-center study Prospective randomized double blind, placebocontrolled,single-center study 20 patients diagnosed with septic shock treated with at least one vasopressor and no corticosteroids N= 10 MB N= 10 control 30 patients diagnosed with severe sepsis; patients receiving corticosteroids or inotropes were excluded N= 15 MB N= 15 control 2mg/kg infusion x 15 mins; 0.25 mg/kg/hr x 2 hours; 0.5 mg/kg/hrx 1 hour; 1 mg/kg/hr x 1 hour 0.5 mg/kg/hrinfusion over 6 hours QE; Quasi-experimental Each study had additional minerals, vitamins added to regimen ND; no difference Critical Care 2014, 18: Pharmacotherapy 2010;30(7):
13 Methylene Blue Outcomes IVIG Increase in MAP Rationale for use is in toxic shock syndrome or refractory septic shock Decreased vasopressor requirements Neutralization of endotoxin and modification of cytokine release Increase in cardiac index SSC does not suggest the routine use of IVIG in adult patients with septic shock (grade 2B) Pharmacotherapy 2010;30(7): Crit Care Med 2007; 35: Sepsis Induced Immune Dysfunction SBITS Trial Randomized, double-blind placebo controlled, multi-center trial N=624 septic shock patients The primary objective was to determine if the administration of IVIG improved mortality among severe sepsis patients Patients were stratified to receive either: Placebo IVIG 0.6 g/kg on day 1; then 0.3 g/kg on day 2 J Clin Invest. 2016;126(1): Crit Care Med 2007; 35:
14 SBITS Trial Results Conclusion The way we have defined sepsis has changed Outcome IVIG, n=321 Placebo, n=303 P value 28 day mortality 126(39.3%) 113 (37.3%) ICU LOS 26 days ± ± Hospital LOS 55.4 ± ± All aspects of EGDT are not needed when resuscitating a patient for septic shock Procalcitonin is a biomarker that still has mixed data which should be used with caution There are emerging adjuvant therapies which may prove beneficial for the treatment of septic shock Crit Care Med 2007; 35: Emerging Immune Modulating Therapies in Sepsis Assessment Question #1 Procalcitonin is a sensitive biomarker to identify someone who is septic True False J Clin Invest. 2016;126(1):
15 Assessment Question #2 Selenium supplementation is appropriate to decrease length of stay in patients hospitalized for sepsis True False Advancements in Sepsis Brian Gilbert, PharmD PGY-1 Pharmacy Resident Jackson Memorial Hospital 3/13/ Assessment Question #3 The use of a central venous catheter to measure ScVO2 is needed for all patients True False 58 15
Nothing to disclose 9/25/2017
Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain
More information9/25/2017. Nothing to disclose
Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain
More informationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care
More informationUpdates in Sepsis 2017
Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials
More informationStaging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
More informationFluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,
More informationEarly Goal-Directed Therapy
Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The
More informationSepsis Management: Past, Present, and Future
Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe
More informationInitial Resuscitation of Sepsis & Septic Shock
Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known
More informationOHSU. Update in Sepsis
Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin
More informationSepsis. From EMS to ER to ICU. What we need to be doing
Sepsis From EMS to ER to ICU What we need to be doing NEHAL BHATT, MD ATHENS PULMONARY, CRITICAL CARE AND SLEEP Objectives 1. Define the changes to the definition of Sepsis 2. Describe the assessment,
More informationSeptic Shock. Rontgene M. Solante, MD, FPCP,FPSMID
Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage
More informationSepsis Management Update 2014
Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma
More informationSepsis is an important issue. Clinician s decision-making capability. Guideline recommendations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%
More informationThe syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa
The syndrome formerly known as Severe Sepsis James Rooks MD Coordinator of critical care education OU College of Medicine, Tulsa Disclosures I have no actual or practical conflicts of interest in relation
More information4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures
Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare
More informationSEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.
SEPSIS: IT ALL BEGINS WITH INFECTION Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. Worth 1 2 3 OBJECTIVES Review the new Sepsis 3 definitions of sepsis
More informationEFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationThe Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital
The Ever Changing World of Sepsis Management Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital COI Disclosures No financial interests to disclose Learning Objectives Review the evolution
More informationSepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program
Sepsis 3 & Early Identification David Carlbom, MD Medical Director, HMC Sepsis Program Disclosures I have no relevant financial relationships with a commercial interest and will not discuss off-label use
More informationJohn Park, MD Assistant Professor of Medicine
John Park, MD Assistant Professor of Medicine Faculty photo will be placed here park.john@mayo.edu 2015 MFMER 3543652-1 Sepsis Out with the Old, In with the New Mayo School of Continuous Professional Development
More informationNo conflicts of interest to disclose
No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,
More informationResuscitation Symposium Resuscitation Literature Update. Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH
Resuscitation Symposium Resuscitation Literature Update Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH Objectives Review recent articles in sepsis New sepsis definition High versus
More informationINTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017
INTENSIVE CARE MEDICINE CPD EVENING Dr Alastair Morgan Wednesday 13 th September 2017 WHAT IS NEW IN ICU? (RELEVANT TO ANAESTHETISTS) Not much! SURVIVING SEPSIS How many deaths in England were thought
More informationFluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS
Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available
More informationWhat is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14
What is the Role of Albumin in Sepsis? An Evidenced Based Affair Justin Belsky MD PGY3 2/6/14 Microcirculation https://www.youtube.com/watch?v=xao1gsyur7q Capillary Leak in Sepsis Asking the RIGHT Question
More informationManaging Patients with Sepsis
Managing Patients with Sepsis Diagnosis; Initial Resuscitation; ARRT Initiation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum
More informationCORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE
CORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE 1 ABBREVIATIONS ACCP = American College of Chest Physicians ARF =
More informationSEPSIS-3: THE NEW DEFINITIONS
SEPSIS-3: THE NEW DEFINITIONS WHAT THEY SHOULD MEAN TO YOU MERVYN SINGER BLOOMSBURY INSTITUTE OF INTENSIVE CARE MEDICINE UNIVERSITY COLLEGE LONDON, UK https://www.youtube.com/watch?v=1s8l5d2xr6w IN THE
More informationDiagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire
Diagnosis and Management of Sepsis and Septic Shock Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire Financial: none Disclosures Objectives: Identify physiologic principles of septic
More informationSepsis or Severe Sepsis? Is there a right thing, and how do we do it?
Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Steven Q Simpson, MD, FCCP, FACP Professor of Medicine Division of Pulmonary and Critical Care University of Kansas Disclosures No
More informationR2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital
R2R: Severe sepsis/septic shock Surat Tongyoo Critical care medicine Siriraj Hospital Diagnostic criteria ACCP/SCCM consensus conference 1991 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
More informationGuidelines are the Future of Sepsis Management Pro
Guidelines are the Future of Sepsis Management Pro R. Phillip Dellinger MD, MCCM Professor and Chair of Medicine Director Adult Health Institute Senior Critical Care Attending Camden NJ USA Objectives
More informationSepsis Update: Focus on Early Recognition and Intervention. Disclosures
Sepsis Update: Focus on Early Recognition and Intervention Jessie Roske, MD October 2017 Disclosures I have no actual or potential conflict of interest in relation to this program/presentation. I will
More informationEarly Goal Directed Therapy in 2015: What Did the Big Trials Teach us?
Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us? Mitchell M. Levy MD, FCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care Warren Alpert Medical School
More informationWhat the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health
What the ED clinician needs to know about SEPSIS - 3 Anna Morgan Consultant EM Barts Health Aims: (1) To review the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (2)
More informationUpdates in Emergency Department Management of Sepsis
Resident Journal Review Updates in Emergency Department Management of Sepsis Authors: Eli Brown, MD; Allison Regan, MD; Kaycie Corburn, MD; Jacqueline Shibata, MD Edited by: Jay Khadpe, MD FAAEM; Michael
More informationPHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT
PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT Melanie Sanchez, RN, MSNE, OCN, CCRN Clinical Nurse III City of Hope National Medical Center HOW THE EXPERTS TREAT HEMATOLOGIC MALIGNANCIES LAS VEGAS, NV
More informationEvidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
More informationThe Use of Metabolic Resuscitation in Sepsis
The Use of Metabolic Resuscitation in Sepsis Jennifer M. Roth, PharmD, BCPS, BCCCP Critical Care Clinical Specialist - Surgical Trauma ICU Baylor University Medical Center Disclosures No conflicts of interest
More informationCurrent State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018
Current State of Pediatric Sepsis Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018 Objectives Review the history of pediatric sepsis Review the current definition of pediatric sepsis Review triage
More informationFluid balance and clinically relevant outcomes
Fluid balance and clinically relevant outcomes Rui Moreno, MD, PhD, Professor UCINC, Hospital de São José Centro Hospitalar de Lisboa Central, E.P.E. INSULT PRIMARY MODS SIRS SECONDARY MODS OUTCOME RECOVERY
More informationSepsis: Identification and Management in an Acute Care Setting
Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationUpdates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign
Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the
More informationDisclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice
Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal
More informationSepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN
Sepsis Early Recognition and Management Therese Hughes, PhD, MPA, RN 1 Sepsis a Deadly Progression Affects millions around the world each year, killing one in four Contributes to approximately 50% of all
More informationRalph Palumbo, MD, FCCP
Ralph Palumbo, MD, FCCP Septic shock is the leading cause of mortality in patients admitted to the ICU In the United States alone there are over 750,000 cases of severe sepsis and septic shock annually
More informationMAKING SENSE OF IT ALL AUGUST 17
MAKING SENSE OF IT ALL AUGUST 17 @SepsisUK Dr Ron Daniels B.E.M. CEO, UK Sepsis Trust CEO, Global Sepsis Alliance Special Adviser to WHO SCALE AND BURDEN @sepsisuk Dr Ron Daniels B.E.M. CEO, UK Sepsis
More informationThe Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust
The Septic Patient Dr Arunraj Navaratnarajah Renal SpR Imperial College NHS Healthcare Trust Objectives of this session Define SIRS / sepsis / severe sepsis / septic shock Early recognition of Sepsis The
More informationEARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer
EARLY GOAL DIRECTED THERAPY : Etat des lieux en 2017 Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles Past-President European
More informationJAMA. 2016;315(8): doi: /jama
JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287 SEPSIS 3 life-threatening organ dysfunction caused by a dysregulated host response to infection organ dysfunction: an increase in the SOFA
More informationSepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program
Sepsis Story At Intermountain Healthcare 2004-2012 Intensive Medicine Clinical Program The International Surviving Sepsis Campaign Was Organized In 2002 During The ESICM International Meeting In Barcelona,
More information2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand
2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand Jack Perkins, MD FACEP, FAAEM, FACP Assistant Professor of Emergency and Internal Medicine Virginia Tech Carilion School of Medicine Why
More informationManagement of Severe Sepsis:
Management of Severe Sepsis: Update from the Surviving Sepsis Campaign Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University NONE Disclosures Review evidence-based international sepsis
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationJawad Nazir, MD, FACP Medical Director, Infection Prevention and Control Avera Health and Avera McKennan Hospital Clinical Associate Professor of
Jawad Nazir, MD, FACP Medical Director, Infection Prevention and Control Avera Health and Avera McKennan Hospital Clinical Associate Professor of Medicine Sanford School of Medicine, Univ of South Dakota
More informationSepsis: What Is It Really?
Sepsis: What Is It Really? Steven D. Burdette, MD, FIDSA, FACP Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship for Premier Health and Miami
More informationPresented by: Indah Dwi Pratiwi
Presented by: Indah Dwi Pratiwi Normal Fluid Requirements Resuscitation Fluids Goals of Resuscitation Maintain normal body temperature In most cases, elevate the feet and legs above the level of the heart
More informationBIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency
BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency Medicine 1 NO CONFLICT OF INTEREST 2 We do not fully understand
More informationSEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP
SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP OBJECTIVES Arise, ProMISE, ProCESS Key points in sepsis management The CMS sepsis core measure COST OF SEPSIS CARE IN US Most
More informationEarly goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia
Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia Early goal-directed therapy in septic shock 2001 Proof-of-concept EGDT trial published NEJM 16%
More informationObjectives. Pathophysiology of Steroids. Question 1. Pathophysiology 3/1/2010. Steroids in Septic Shock: An Update
Objectives : An Update Michael W. Perry PharmD, BCPS PGY2 Critical Care Resident Palmetto Health Richland Hospital Review the history of steroids in sepsis Summarize the current guidelines for steroids
More informationSepsis Learning Collaborative: Sepsis New Definitions
Sepsis Learning Collaborative: Sepsis New Definitions Sepsis 3, a New Definition Todd L. Slesinger, MD, FACEP, FCCM, FCCP, FAAEM Program Director and Academic Chair Department of Emergency Medicine Disclosures
More informationEffectively Managing Sepsis Denials
Effectively Managing Sepsis Denials Krysten Brooks, RN, BSN, MBA Senior Inpatient Consultant 3M Health Information Systems This is the Full Title of a Session Atlanta, GA 1 Learning Objectives At the completion
More informationTop Sepsis Studies
A75M233/A75M529 Monday 08:00-09:15 Wednesday 14:45-16:00 Maureen A Seckel APRN, ACNS-BC, CCRN, CCNS, FCCM Critical Care CNS and Sepsis Leader Christiana Care Health Services, Newark, DE Top Sepsis Studies
More informationBC Sepsis Network Emergency Department Sepsis Guidelines
The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to
More informationFLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL
FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL COLLEGE NOVEMBER 10 TH 2017 TEXAS SCCM SYMPOSIUM Disclosures
More informationUpdate on Sepsis Diagnosis and Management
CHAPTER 12 Update on Sepsis Diagnosis and Management Kevin Alexander, DPM INTRODUCTION Sepsis and septic shock have become a large problem in the health care system that affects at least 1 million people
More informationBasics from anatomy and physiology classes Local tissue reactions
Septicaemia & SIRS Septicaemia is a life-threatening condition that arises when the physical reaction to an infection, causes damage to tissue and organs Basics from anatomy and physiology classes Local
More informationSepsis - A Year in Transition
Sepsis - A Year in Transition Todd L. Allen, MD, FACEP Chair, Emergency Department Development Team; Assistant Quality Officer, Institute for Healthcare Leadership Russell R. Miller, III, MD, MPH, FCCM
More informationSUCCESS IN SEPSIS MORTALITY REDUCTION. Maryanne Whitney RN MSN CNS Improvement Advisor, Cynosure Health HRET HEN AK Webinar
SUCCESS IN SEPSIS MORTALITY REDUCTION Maryanne Whitney RN MSN CNS Improvement Advisor, Cynosure Health HRET HEN AK Webinar Got Sepsis? Now What?- Alerts & Bundles Maryanne Whitney RN, MS, CNS Improvement
More information6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,
Sepsis Management and Hemodynamics Javier Perez-Fernandez, M.D., F.C.C.P. Medical Director Critical Care Services, Baptist t Hospital of Miamii Medical Director Pulmonary Services, West Kendall Baptist
More informationUTILITY of ScvO 2 and LACTATE
UTILITY of ScvO 2 and LACTATE Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland THIS TRIP SPONSORED AND PAID FOR BY STRUCTURE Physiology -
More informationThe Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya
The Usefulness of Sepsis Biomarkers Dr Vineya Rai Department of Anesthesiology University of Malaya 1 What is Sepsis? Whole Body Inflammatory State + Infection 2 Incidence and Burden of Sepsis in US In
More informationEarly Recognition and Timely Management of Sepsis Amid Changes in Definitions
Early Recognition and Timely Management of Sepsis Amid Changes in Definitions Tze Shien Lo, MD, FACP Chief, Infectious Disease Service Fargo VA Medical Center Professor of Medicine UND School of Medicine
More information4/4/2014. Of patients diagnosed with sepsis 50% will develop severe sepsis 25% will develop shock. SIRS Sepsis Severe Septic Sepsis Shock.
A summary of pathophysiology, therapeutics, and how the pharmacy TECHNICIAN can help improve OUTCOMES Anthony Nelson 2014 Pharm.D. Candidate Tricia Aggers, Pharm.D. Affiliate Faculty, ISU College of Pharmacy
More informationSepsis and Shock States
Sepsis and Shock States Presented By: Cynthia Webner BSN, RN, CCRN, CMC www.cardionursing.com CNEA 2009 1 INFECTION Inflammatory response to microorganisms, or Invasion of normally sterile tissues SYSTEMIC
More informationSURVIVING SEPSIS: Early Management Saves Lives
SURVIVING SEPSIS: Early Management Saves Lives Pat Posa RN, BSN, MSA System Performance Improvement Leader St. Joseph Mercy Health System Ann Arbor, MI Patricia.posa@stjoeshealth.org Objectives a. Understand
More informationLooking for sepsis. Sepsis: Update. Prevalence of High Profile Dzs. Screening and risk stratification. Mortality of High Profile Diseases
Sepsis: Update Prevalence of High Profile Dzs Edward A. Panacek, MD, MPH Professor and Chair, Emergency Medicine USA Medical Center, Mobile, AL NDAFP Conference Big Sky. 2016 Syllabus Angus Crit Care Med
More informationTailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018
Tailored Volume Resuscitation in the Critically Ill is Achievable Heath E Latham, MD Associate Professor Fellowship Program Director Pulmonary and Critical Care Objectives Describe the goal of resuscitation
More informationSepsis care and the new core measures
Sepsis care and the new core measures Daniel S. Hagg, MD January 15, 2016 Outline What is sepsis? A brief history of sepsis care How should we take care of septic patients now? Core measures What strategies
More informationSepsi: nuove definizioni, approccio diagnostico e terapia
GIORNATA MONDIALE DELLA SEPSI DIAGNOSI E GESTIONE CLINICA DELLA SEPSI Giovedì, 13 settembre 2018 Sepsi: nuove definizioni, approccio diagnostico e terapia Nicola Petrosillo Società Italiana Terapia Antiinfettiva
More informationUpdate in Critical Care Medicine
Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update
More informationUpdate in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.
Update in Sepsis Bill Janssen, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Conflicts of Interest: None A 62 year-old female presents to the ED with fever,
More informationIntravenous Vitamin C. Severe Sepsis Acute Lung Injury
Intravenous Vitamin C Severe Sepsis Acute Lung Injury Alpha A. (Berry) Fowler, III, MD Professor of Medicine VCU Pulmonary Disease and Critical Care Medicine I Have No Disclosures Bacterial Sepsis Approximately
More informationSepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand
Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand Vital signs Symptoms LAB BT > 38.3 or < 36 ๐ C HR > 90 bpm RR > 20 /min
More informationSepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016
Sepsis Care and the New Core Measures Daniel S. Hagg, MD January 15, 2016 Outline What is sepsis? A brief history of sepsis care How should we take care of septic patients now? Core measures What strategies
More informationObjectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy
Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of
More informationSepsis and Septic Shock: New Definitions for Adults
PL Detail-Document #320424 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER April 2016 Sepsis and Septic
More informationDiagnosis and Management of Sepsis. Disclosures
Diagnosis and Management of Sepsis David Shimabukuro, MDCM Medical Director, 13 ICU Physician Lead, UCSF Sepsis Bundle Compliance and Mortality Reduction I have no disclosures Disclosures 1 The following
More informationWhere did it all begin?
EXPLORE Healthcare Summit Sepsis: Can We Finally Just Relax on the SOFA? Mark Keuchel, D.O. Background: 1. Sepsis is a wide-spectrum disease process that remains poorly understood 2. Early-goal directed
More informationSepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment
Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus
More informationPatient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014
Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Presenters Mark Blaney, RN Regional Nurse Educator CHI Franciscan Health Karen Lautermilch Director, Quality & Performance
More informationA BRIEF HISTORY OF SEPSIS. Euan Mackay
A BRIEF HISTORY OF SEPSIS Euan Mackay Aims History of sepsis definition Validity of new definition Hippocrates 4 th century BC Hippocrates introduced the term "σήψις the process of decay or decomposition
More informationADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS
ADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS ERIC H GLUCK MD JD FCCP FCCM DIRECTOR OF CRITICAL SERVICES SWEDISH COVENANT HOSPTIAL DISCLOSURES: Speaking engagements and consulting:
More informationYear in Review 2014: Critical Care Medicine
Disclosures Year in Review 2014: Critical Care Medicine I receive laboratory support from CytoVale Diagnostics for research on early sepsis diagnostics Eric J. Seeley, M.D., F.C.C.P. Assistant Professor
More information3/14/2017. Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care. Objectives. Developmental Response to Sepsis
Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care March 20, 2017 Reid WD Farris, MS MD Objectives Review the evolution & current state of the pediatric septic shock treatment guidelines
More information